Cholestasis includes retention of conjugated bilirubin, bile salts and other components of the bile. It is not a disease; rather, it is a symptom of many diseases. This study aimed at finding out the etiological diagnosis of chronic cholestatic liver diseases among cases of cholestasis admitted to El-Shatby Children Hospital-University of Alexandria, Egypt during a 2 years period. Seventy infants and children with their ages ranging from 1 to 36 months were included in the study. Various diagnostic modalities were used to establish their diagnosis.
INTRODUCTION
Cholestasis includes retention of conjugated bilirubin, bile salts and other components of the bile. It is not a disease; rather, it is a symptom of many diseases therefore, it is a signal that disease exists. The mechanisms by which diseases produce cholestasis can be classified as either hepatocellular or obstructive cholestasis. ( 1 )
The first diagnostic concern of cholestatic disorders should be the differentiation of hepatocellular from obstructive cholestasis, because it represents the differentiation between medical versus surgical disorders. All disorders that deserve intervention in the first few months of life are obstructive disorders, and their timely identification can improve outcome. ( 2 ) Because of the frequent lack of distinctive clinical features leading to differentiation between hepatocellular and obstructive disorders, cholestatic infants require a stepwise, comprehensive evaluation. Diagnostic schemata should incorporate clinical, biochemical, radiological and histological features. However, at any point during the process of evaluation, a serologic test or imaging study may establish the probable cause of cholestasis. ( 3 ) The aim of the present study was to find-out the etiological diagnosis of chronic cholestatic liver diseases among cases of cholestasis presented to the pediatric outpatient clinic at El-Shatby Children Hospital-University of Alexandria over a 24 months period.
PATIENTS AND METHODS
Seventy patients (36 females and 34 males) with their ages ranging from 1 to 36 months were enrolled in the study They were fulfilling the clinical and laboratory criteria of chronic cholestasis, that is cholestasis persisting beyond two weeks of age in neonates, cholestasis which is expected to persist in infants, or cholestasis lasting for four weeks or more in children. ( 4 ) An informed consent was taken from the parents of all patients included in the study. Patients with the classical clinical picture of acute hepatitis and those with cholestasis showing signs of end stage liver failure were excluded from the study.
Every patient was subjected to a full history taking stressing on the age , sex, birth weight ,onset and duration of jaundice, colour of urine and stool as well as serological evidence of maternal infectious diseases . Also every patient was subjected to thorough clinical examination, laboratory investigations including total and direct serum bilirubin, serum bile salts ( 5 ), the cholestatic enzymes alkaline phosphatase (ALP) and gamma glutamyle transpeptidase (GGT) ( 6 , 7 ), aspartate transaminase (AST), alanine transaminase (ALT), prothrombin time and activity, serum albumin, fasting blood glucose ,urine examination for bilirubin,bile salts and reducing substances.
Serological tests for hepatitis B surface antigen, hepatitis C virus IgG antibodies , Toxoplasma ,Rubella, Cytomegalovirus (CMV) and herpes virus(HSV) i,eTORCH IgM antibodies were done using ELISA technique. Alpha fetoprotein was measured by chemiluminescence and alpha 1 antitrypsin level by immunoturbidimetry .Moreover, alpha 1 antitrypsin phenotyping by isoelectric focusing ( 8 ) was done for deficient cases.
Radiological imaging (abdominal ultrasound seeking for the gall bladder and Triangular cord sign( 9 ) ) and radionuclide imaging (Tc-99m-HIDA scinigraphy) ( 10 ). Lastely percutaneous liver biopsy was done using Manghini technique( 11 , 12 ),a small part of the biopsy sample was immersed in gluteraldehyde for transmission electron microscopy and the rest of the sample was fixed in 10% buffered formaline and is processed in the ordinary paraffin embedding method, serial sections 3 ?m thick were made and stained by hematoxylene and eosin, trichrome, reticulin,periodic acid schiff (PAS),and PAS after diastase.
RESULTS
All cases had jaundice and dark urine , the onset of jaundice ranged from one day to 20 months after birth and continued till the time of presentation except in one case where the jaundice appeared at the age of 20 months and took an intermittent course .
Patients were classified according to the various diagnostic tests into 3 groups (fig 1 ):
Group 1: Neonatal hepatitis (41.4%) ,with transaminase level more than 5 folds elevated and GGT less than 5 folds elevated.
Group II : Biliary atresia (24.3%),with transaminase level less than 5 folds elevated and GGT more than 5 folds elevated.
Group III : Miscellaneous (34.3%) . Table 1 shows the etiological diagnosis of neonatal hepatitis  cases, while table (II) shows the final diagnosis of all cholestatic patients included in the study . Among the clinical parameters used in this study only birth weight, age of onset of jaundice and presence of splenomegaly were found to be useful. Infants with neonatal hepatitis were found to have low birth weight and later onset of jaundice than those having biliary atresia table (I).
Moreover splenomegaly was found in higher percentage in infants with neonatal hepatitis compared to biliary atresia cases Table (I ) Anthropometric data and onset of jaundice:. In 65 infants, elevated levels of serum transaminases (reference value is up to 40 u/L)were found, of those 7 patients had markedly elevated level (>200 u/L),58 had moderate elevation between 70 and 200 U/L. The remaining 5 patients had normal transaminases level.
Serum alkaline phosphatase level (reference value 3-13 K&A)was high in all infants with a mean of 90±30 k&A. Gamma glutamyl transpeptidase level was normal in 3 infants (10-40 U/L), low in 2 (<10 U/L) and high in 65 infants (> 40 U/L). In those with elevated levels, 18 had GGT greater than five fold elevation (>200 U/L) and 47 had GGT less than five fold elevation (< 200 U/L).
In patients who had normal and low GGT (5 cases),4 had elevated serum bile salts level, while the 5 th had normal serum bile salts (< 9.8 ?mol/L) as well as normal GGT, ALP, AST and ALT levels.
Impaired synthetic liver function (reflected by serum albumin and prothrombin activity) were detected in the majority of cases. Fasting blood glucose level was normal in all cases except two who had hypoglyceamia.
Urine tests for conjugated bilirubin and bile salts were done for all cases and revealed positive results. On the other hand ,urine samples were negative for reducing substances .
By abdominal ultrasound exmination , two patients were proved to have choledochal cysts. Figure 3 ", non syndromic intrahepatic bile duct paucity(5.71%), Biliary cirrhosis(5.71%) ,and Idiopathic " with equivocal liver biopsy"(5.71%). We compared different diagnostic modalities in the diagnosis of neonatal hepatitis and biliary atresia. (Table  V&VI ) . Abdominal ultrasonography is an excellent test in excluding choledochal cyst as a cause of infantile cholestasis. In this study abdominal ultrasound was found to be more specific for the diagnosis of biliary atresia (86.2% versus 30.9%) and more accurate (82.3% versus 52.9%) but less specific (64.7%% versus 82.8%). On the other hand hepatobiliary scintigraphy is a sensitive but less specific test in differentiating biliary atresia from intrahepatic cholestasis.
DISCUSSION
Cholestasis develops in response to a wide variety of causes. Irrespective of the etiology, its pathophysiological consequences on liver cell function are the same and early recognition and treatment could prevent permanent liver damage.
Even when treatment is not available or effective, infants with progressive liver disease usually benefit from efforts to provide optimal nutritional support and medical management of complications.
Several works had been done to study the etiological incidence of cholestasis and reported variable results with the neonatal hepatitis remaining the commonest etiology of cholestatic syndromes ranging from 38% ( 11 to 79% . ( 13 ) CMV infection was found to be the commonest cause of neonatal hepatitis by some workers( 11 , 15 ),as proved in the present study . However, we did not detect cases with Rubella, hepatitis B, hepatitis C or HIV infection in our patients. The incidence of non-syndromic bile duct paucity in this study was 2.8% while the syndromic bile duct paucity (Alagille's syndrome) was not found. These findings agree with the results of the John's study ( 11 ) but others reported higher incidence of Allagille's syndrome ( 15 , 22 ) might be due to different genetic background.
CONCLUSION
From the present study we can conclude that:
Neonatal hepatitis is the commonest cause of infantile cholestasis and biliary atresia is the second common cause.
Routine laboratory tests as well as tests for specific hepatic disorders are important for the diagnosis and evaluation of cholestasis in pediatric age.
Histological study is a valuable tool in etiological diagnosis of cholestasis provided that it is done by an expert hands and lead to no complications.
Metabolic liver diseases are clinically excellent simulators to the common pediatric illnesses and should be considered and searched for during the work up of cholestatic disease diagnosis in pediatrics.
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